GTP cyclohydrolase I (GTPCH ) (EC 3.5.4.16 ) is a member of the GTP cyclohydrolase family of enzymes . GTPCH is part of the folate and biopterin biosynthesis pathways . It is responsible for the hydrolysis of guanosine triphosphate (GTP) to form 7,8-dihydroneopterin triphosphate (7,8-DHNP-3'-TP, 7,8-NH2 -3'-TP).
Gene
GTPCH is encoded by the gene GCH1 . Several alternatively spliced transcript variants encoding different isoforms have been described; however, not all of the variants give rise to a functional enzyme.[ 5]
Clinical significance
At least 94 disease-causing mutations in this gene have been discovered.[ 6] Mutations in this gene are associated with two disorders: autosomal recessive GTP cyclohydrolase I deficiency and autosomal dominant GTP cyclohydrolase I deficiency . These may present with malignant phenylketonuria (PKU) and hyperphenylalaninemia (HPA)[ 5] and lead to a lack of certain neurotransmitters (dopamine , norepinephrine , epinephrine and serotonin ). The dominant form, with mutation in only one of the two alleles for GTP cyclohydrolase I, causes dopamine-responsive dystonia , characterized by childhood-onset dystonia . Patients with the recessive form have mutations in both alleles for GTP cyclohydrolase I. Patients present with developmental delays and neurological dysfunction with trunk hypotonia , hypertonia of the extremities, abnormal movements, tremors , convulsions, and sometimes autonomic dysfunction .[ 7] Response to treatment is variable and the long-term and functional outcome is unknown. To provide a basis for improving the understanding of the epidemiology, genotype/phenotype correlation and outcome of these diseases their impact on the quality of life of patients, and for evaluating diagnostic and therapeutic strategies a patient registry was established by the noncommercial International Working Group on Neurotransmitter Related Disorders (iNTD).[ 8]
Function
The transcribed protein is the first and rate-limiting enzyme in tetrahydrobiopterin (THB, BH4 ) biosynthesis, catalyzing the conversion of GTP into 7,8-DHNP-3'-TP. THB is an essential cofactor required by the aromatic amino acid hydroxylase (AAAH) and nitric oxide synthase (NOS) enzymes in the biosynthesis of the monoamine neurotransmitters serotonin (5-hydroxytryptamine (5-HT)), melatonin , dopamine , norepinephrine (noradrenaline), and epinephrine (adrenaline), and nitric oxide (NO), respectively.[citation needed ]
GTPCH (GCH1) and tetrahydrobiopterin were found to protect against cell death by ferroptosis . Tetrahydrobiopterin (BH4 ) acts as a potent, diffusable antioxidant that resists oxidative stress and enables cancer cell survival.[ 9]
See also
References
^ a b c GRCh38: Ensembl release 89: ENSG00000131979 – Ensembl , May 2017
^ a b c GRCm38: Ensembl release 89: ENSMUSG00000037580 – Ensembl , May 2017
^ "Human PubMed Reference:" . National Center for Biotechnology Information, U.S. National Library of Medicine .
^ "Mouse PubMed Reference:" . National Center for Biotechnology Information, U.S. National Library of Medicine .
^ a b "Entrez Gene: GCH1 GTP Cyclohydrolase 1 (DOPA-Responsive Dystonia)" .
^ Šimčíková D, Heneberg P (December 2019). "Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases" . Scientific Reports . 9 (1): 18577. Bibcode :2019NatSR...918577S . doi :10.1038/s41598-019-54976-4 . PMC 6901466 . PMID 31819097 .
^ Longo N (June 2009). "Disorders of biopterin metabolism". Journal of Inherited Metabolic Disease . 32 (3): 333–42. doi :10.1007/s10545-009-1067-2 . PMID 19234759 . S2CID 13117236 .
^ "Patient registry" .
^ Kraft VA, Bezjian CT, Pfeiffer S, Ringelstetter L, Müller C, Zandkarimi F, Merl-Pham J, Bao X, Anastasov N, Kössl J, Brandner S, Daniels JD, Schmitt-Kopplin P, Hauck SM, Stockwell BR, Hadian K, Schick JA (January 2020). "GTP Cyclohydrolase 1/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling" . ACS Central Science . 6 (1): 41–53. doi :10.1021/acscentsci.9b01063 . PMC 6978838 . PMID 31989025 .
Further reading
External links
PDB gallery
1fb1 : CRYSTAL STRUCTURE OF HUMAN GTP CYCLOHYDROLASE I
1is7 : Crystal structure of rat GTPCHI/GFRP stimulatory complex
1is8 : Crystal structure of rat GTPCHI/GFRP stimulatory complex plus Zn
1wpl : Crystal structure of the inhibitory form of rat GTP cyclohydrolase I/GFRP complex
Activity Regulation Classification Kinetics Types
Fat soluble vitamins
Water soluble vitamins
Nonvitamin cofactors
Activity Regulation Classification Kinetics Types